What a Multi-Location Veterinary Group Is Worth in 2026

Key takeaways

• A group is more than added-up revenue: consolidated normalized EBITDA and the durability of every location drive a defensible valuation.
• More locations do not guarantee a premium: buyers distinguish transferable group infrastructure from several practices bundled under one owner.
• Every site still gets tested: doctor coverage, leases, growth sources, records, capital needs, and contribution to group earnings remain visible.
• Concentration can survive expansion: revenue, leadership, or doctor capacity may still depend on one hospital or person.
• The practical next move is evidence: build a consolidated EBITDA bridge and reconcile it to consistent site-level records before testing buyer interest.

The contrast shows up before I open the financials.

On the same morning, I can walk through one sister hospital where the team solves problems without the owner. Appointments move.

Decisions get made.

Then I cross town.

At the second hospital, a staffing question waits, a doctor needs approval, and the schedule stalls until the owner arrives.

Same logo. Same tax return.

Different transferability.

Transferability means the likelihood that earnings, staff, clients, leadership, and operating routines continue under new ownership.

In 2026, a multi-location veterinary group, meaning 2 or more practices under common ownership and coordinated management, does not equal combined revenue; valuation starts with consolidated normalized EBITDA, the group’s earnings after defensible adjustments.

It removes intercompany items consistently, keeps recurring costs for groupwide functions, and lets buyers test site earnings, doctor coverage, leases, leadership, systems, reinvestment needs, and dependencies.

What is a multi-location veterinary group worth in 2026?

A group’s value begins with consolidated normalized EBITDA, then moves with site-level earnings quality, leadership, doctor coverage, shared systems, growth, and concentration risk across every hospital, without letting a strong site hide a weak one.

No verified source provides a current multi-site valuation range, so location count alone cannot support a premium or reliable headline number.

A multi-location veterinary group means 2 or more veterinary practices under common ownership and coordinated management. That definition describes structure, not quality.

I have seen the distinction become obvious during a single morning’s walk-through. One group operates as an organization; another operates as the owner’s personal circuit between hospitals.

Both may report the same consolidated revenue. Buyers will not treat them as the same asset.

The complete veterinary practice valuation method owns the broader framework. The group application adds a second lens: can each location stand on its own, and does the shared layer improve the whole?

That is why I start below the headline total.

One hospital may create dependable cash flow. Another may consume management time and facility spending while contributing little operating profit.

The value sits in the quality and continuation of group earnings. The number of addresses comes later.

How does consolidated normalized EBITDA work for veterinary groups in 2026?

Consolidated normalized EBITDA is group earnings before interest, taxes, depreciation, and amortization after defensible adjustments, with intercompany items removed consistently while truly recurring costs for groupwide functions remain in the calculation for valuation purposes.

The purpose is to reveal transferable group earnings, not move expenses between entities until the result looks larger.

Start with every location and the shared-services entity, if one exists. Reconcile revenue, payroll, rent, supplies, management costs, and intercompany charges on the same basis.

That sounds basic. It rarely is.

One location may pay the regional manager. Another may carry recruiting costs.

A shared entity may hold software, bookkeeping, or marketing expenses that support every hospital.

If those costs continue after a sale, they belong in the operating picture. If an intercompany charge merely moves money within the group, it should not create imaginary profit or expense.

The full veterinary practice EBITDA add-backs guide explains normalization. Group valuation adds a consistency test: the same treatment must apply across locations and years.

I also compare service mix.

AVMA’s November 2024 analysis, updated in May 2025, describes examinations, pharmacy, laboratory, vaccinations, surgery, imaging, and dentistry as distinct contributors to average practice revenue when owners compare sister hospitals carefully.

For a group, that context creates a sharper question. Does one site’s margin differ because its clinical mix is different, or because records, pricing, staffing, and expense coding are inconsistent?

The EBITDA bridge should answer that before a buyer asks.

Why must buyers test every veterinary location in 2026?

Consolidated results can hide a weak hospital, deferred facility work, a fragile lease, or earnings concentrated in one doctor, even when the group total looks calm and convincing on paper.

Buyers review each site to see which locations create durable profit, which absorb shared resources, and whether group earnings will continue after the owner leaves under a post-sale transition plan.

This is where a clean consolidated statement can become misleading.

Suppose one location grows while another declines.

The total may look stable, but a buyer could find the second hospital losing doctors, delaying equipment replacement, or relying on a lease that changes during the same measured period.

Today’s Veterinary Business stated the narrow rule plainly in 2019: low-profit practices have low values. It separated fixable operating problems from harder facility, culture, and retention risks.

Putting a weak location beside a strong one does not erase that principle.

I want to know what each hospital earns before shared allocations, which costs truly belong there, and what reinvestment the buyer inherits.

What a buyer tests at each location in 2026

Site-level test	What the buyer asks	Evidence that helps
Earnings quality	Is profit recurring?	Consistent site statements
Doctor coverage	Who carries production?	Doctor-level trends
Lease and facility	Will occupancy hold?	Lease terms and capital plan
Local demand	What drove growth?	Visits, pricing, and capacity
Systems and data	Can results be compared?	Common reporting and controls
Required reinvestment	What must be funded next?	Equipment and facility needs

The table is not a scorecard. None of the rows carries an automatic weight.

They are the questions that stop a buyer from accepting a consolidated total on faith.

Does owning multiple veterinary locations create a platform premium in 2026?

No. Multiple locations can support a premium when leadership, systems, reporting, and doctor coverage make the group transferable and expandable, but 2 sites do not create that result automatically for a buyer.

The evidence supports a directional scale benefit, not a current multi-location multiple table or guaranteed premium.

QuantPillar’s Q1 2026 guide lists 8×–14× for veterinary practices and names multi-location scale as a valuation driver. It does not break out a verified range for groups.

Octus’s January 2026 analysis describes practice-level acquisitions in the mid-to-high single digits and explains why combined infrastructure can create different group economics. Its evidence does not give owners a universal group price sheet.

Provident Healthcare Partners drew a similar distinction in Q2 2024. Its institutional-market commentary placed premium platform-caliber assets above sizeable add-ons, but that dated observation is not a current promise for every multi-site owner.

Here, platform-quality means leadership and systems can support the existing hospitals and potentially integrate more. An add-on is a practice a larger group can fold into infrastructure already in place.

A platform-quality group has leadership, systems, reporting, and doctor coverage that can support existing hospitals and potentially integrate more. In owner language, it moves without the seller serving as every location’s operating system.

An add-on is a practice a larger group can integrate into infrastructure it already has.

The classification is relative.

The same veterinary group may look platform-quality to a buyer entering its geography and add-on-like to another buyer with leadership already nearby. Strategy, systems, doctor coverage, and regional fit change the interpretation.

I would never turn either label into a guaranteed multiple. The evidence must show what the group can actually support.

How do shared leadership and systems affect veterinary group value in 2026?

Shared leadership and systems can turn separate hospitals into a transferable group when decisions, reporting, recruiting, scheduling, and financial controls work consistently without the owner across every hospital through a transition.

Buyers test whether that infrastructure truly supports each site or merely appears as overhead on a consolidated statement.

Shared services are functions used across locations, such as finance, recruiting, purchasing, scheduling, or marketing. The value is not centralization for its own sake.

Repeatability is the value.

A regional leader who can resolve staffing problems across hospitals is different from an owner carrying the title while making every decision personally.

The same distinction applies to reporting. A common practice-management system means little if locations code services differently or close their books on different schedules.

AVMA’s October 2025 productivity benchmark reported $554,982 in revenue per veterinarian and 2.76 full-time-equivalent veterinarians for the average practice in 2024.

Those figures are context, not buyer requirements. I use them to ask why doctor productivity and capacity differ across sister hospitals.

AVMA’s separate profitability analysis links service mix and staffing use to practice efficiency. In a group, those operating differences should be explainable rather than buried inside a blended average.

Transferable systems make the explanation easier.

They let a buyer see who owns each process, how exceptions are handled, and whether performance can be repeated. A manual process living in the owner’s head does the opposite.

How does concentration risk change veterinary group valuation in 2026?

Concentration risk means too much of a group’s revenue, earnings, doctor coverage, referrals, or facility capacity depends on one source, even after the owner has expanded to several nearby addresses.

More locations do not automatically create diversification when one hospital, owner, associate, lease, or local market can still materially change consolidated results.

I see owners count addresses when they should count dependencies.

A group with several locations may still generate most of its earnings at one flagship hospital. It may rely on one doctor for surgery, one leader for staffing, or one landlord for several nearby facilities.

That is not broad diversification. It is concentrated performance wearing a larger footprint.

Geography can cut both ways.

Nearby hospitals may share staff and build regional density. They may also share the same labor shortage, demand shock, weather event, or referral pattern.

The buyer’s question is simple: what can break the earnings story?

Revenue concentration is only one answer. Doctor production, referral sources, supplier dependence, leases, and deferred capital can carry the same risk.

The fix is not to scatter locations across a map.

It is to document the dependency, show how leadership manages it, and build credible coverage where one person or site still matters too much without heroic operating assumptions after closing.

What does 2026 market evidence say about veterinary group values?

The 2026 evidence shows renewed broad pet-sector platform activity alongside compressed reported multiples and price-led veterinary revenue growth, all at once, which is why market headlines can mislead an owner so easily.

Those signals describe the environment, not one group’s value.

An owner’s answer still depends on consolidated earnings, site quality, leadership, systems, and buyer-specific strategic fit.

Capstone Partners‘ April 2026 update showed the rebound numerically: 18 announced or completed pet-sector deals year to date, compared with 8 during the corresponding window in the prior year.

The mix included 3 platform deals and 5 add-ons backed by investment firms.

That is pet-sector context, not a veterinary-group valuation range.

R.L. Hulett reported another side of the market.

Its broad pet-sector median for reported private-equity deals fell from 16.8× EBITDA in 2024 to 9.9× in 2025.

The report also counted 8 veterinary-care deals in Q4 2025. Neither figure tells us what a specific companion-animal group will command.

Operating evidence is mixed too.

iVET360’s vendor-reported 2025 benchmarks showed 2.6% revenue growth, a 4.7% decline in transaction volume, and a 7.5% increase in average transaction charge.

Price, not volume, carried the reported growth. Buyers will want to know whether each location’s growth came from sustainable demand, pricing, added doctor capacity, or some combination.

The buyer pool is not new.

VetIntegrations counted 48 major veterinary groups active in North America in late 2022.

That dated count proves only that dozens of groups were already active then. It is not a current census.

The market can reward a strong group without rescuing weak evidence. Sector headlines never replace location-level proof.

How should enterprise value be separated among veterinary locations in 2026?

Enterprise value is the value of group operations before cash, debt, taxes, transaction-specific adjustments, and other closing economics that become fully known only when a real deal structure exists on paper.

It is not the owner’s net proceeds. Allocating value among locations is a separate analysis because each site contributes different earnings, assets, risks, and future capital needs.

A headline group value can be useful, but it is not the end of the work.

The locations may sit in separate entities. Real estate may have different ownership.

Debt, leases, equipment obligations, or partner interests may not follow the same lines as operating profit.

I separate the issue into distinct questions.

First, what are the consolidated operations worth? Second, how does the analysis attribute that value among locations or entities?

Third, what does the transaction produce for the owner after the actual closing economics?

Those answers are not interchangeable.

A weak site may receive less allocated operating value even when its building matters. A strong site may contribute more EBITDA while relying heavily on shared leadership paid elsewhere.

Allocation should follow the facts, not a convenient revenue percentage.

The bridge to net proceeds belongs with the owner’s legal, tax, and accounting advisers after the structure is known. A veterinary group valuation should never promise the final check from enterprise value alone.

How can an owner prepare a defensible veterinary group valuation in 2026?

Build a consolidated EBITDA bridge, reconcile it to consistent site-level statements, and document doctor production, leadership roles, leases, growth sources, systems, and near-term capital needs before asking buyers to react to the whole group.

Then test the evidence through a confidential competitive process, because preparation creates credibility while real buyer interest tests the market.

Keep the preparation narrow enough to be useful.

This article is not the complete sale checklist. The essential valuation file shows how group earnings tie to each hospital and why those earnings should continue.

I would want monthly site statements on a consistent basis, a clean shared-cost allocation, doctor-level production trends, and a plain map of leadership responsibilities for every hospital in the group.

Add lease facts and known capital needs. Then explain recent growth at each site without smoothing the differences into one group percentage.

The owner’s guide to selling a veterinary practice covers the broader transaction path. For valuation, the aim is a coherent evidence trail from location records to consolidated earnings.

When I walk an owner through this over dinner, the hard part is rarely multiplication. It is deciding which earnings a careful buyer can defend after examining every site.

That preparation comes before competition.

What should a multi-location veterinary group owner do next in 2026?

Do not add location revenue or chase the highest published platform multiple; build the consolidated EBITDA bridge, expose each site’s strengths and risks, and decide whether leadership and systems truly transfer without the owner.

Then let qualified buyer evidence, gathered confidentially and competitively, establish what the group can command.

That last step needs discipline.

Our Elite Selling System works like a doorman with a velvet rope: we hand-select and vet every buyer allowed to bid, then create a private window where qualified interest must compete.

For a multi-location group, that process does more than collect numbers. It shows which buyers see platform potential, which see an add-on, and what evidence supports each position.

If you want that analysis before opening a sale conversation, start with a free, confidential veterinary group value estimate.

We will examine the consolidated earnings and the locations beneath them. The goal is not a flattering headline; it is a value position that can survive buyer scrutiny.

A group with several signs above several doors is easy to describe. A transferable operating model is harder to build, and far more important to prove.

---

Frequently asked questions for veterinary group owners in 2026

How is veterinary group valuation calculated in 2026?

A defensible valuation starts with consolidated normalized EBITDA, then tests each location’s earnings quality, doctor coverage, lease, leadership, systems, growth source, and required reinvestment under consistent operating assumptions for valuation purposes.

Buyers apply a supportable multiple only after deciding whether those group earnings are transferable.

Does owning 2 veterinary locations create a premium in 2026?

No. Two locations establish a multi-location group, not an automatic premium.

A buyer may value scale when leadership, reporting, doctor coverage, and shared systems work across the group in that buyer’s operating model; 2 owner-dependent sites may still look like bundled practices.

What is consolidated normalized EBITDA for a veterinary group in 2026?

It is group earnings before interest, taxes, depreciation, and amortization after defensible adjustments, with intercompany charges eliminated consistently while recurring shared-service costs remain correctly inside the operating picture for a buyer.

The calculation should reveal transferable operating earnings rather than hide costs at one entity or location.

What is a platform-quality veterinary group in 2026?

A platform-quality group has leadership, systems, reporting, and doctor coverage that can support its current locations and potentially integrate more.

The label is buyer-relative, so a group may fit one buyer’s platform strategy while another sees it as an add-on to infrastructure already operating nearby with established leadership and reporting systems.

Why do buyers review each veterinary location separately in 2026?

Consolidated results can hide a weak site, deferred facility work, a fragile lease, or earnings concentrated in one doctor.

Buyers review location-level performance to learn which hospitals create durable earnings, which consume shared resources, what must change after closing, and what each hospital contributes after fair allocations to measured consolidated profit.

What is concentration risk in a veterinary group in 2026?

Concentration risk means too much revenue, profit, doctor coverage, referrals, or facility capacity depends on one source.

More locations do not automatically diversify a group; buyers test whether one hospital, owner, associate, lease, or local market can materially change group earnings despite the wider footprint on paper alone.

Is enterprise value the owner’s net proceeds in 2026?

No. Enterprise value measures the value of group operations before cash, debt, taxes, transaction-specific adjustments, and other closing economics.

Value allocated among locations is a separate analytical exercise, while net proceeds depend on actual transaction terms and the owner’s legal, tax, and accounting facts after structure is fully known and documented.

What should I prepare for a veterinary group valuation in 2026?

Prepare a consolidated EBITDA bridge, consistent site-level statements, doctor-production detail, leadership roles, leases, growth trends, capital needs, and evidence that shared systems work before a serious valuation review begins with qualified buyers.

This is the essential valuation evidence, not a complete sale-document checklist.

---

Sources

Veterinary valuation and group-market evidence

1. QuantPillar. “2025-2026 Private Market Valuation Multiples: The Definitive Cheat Sheet.” Q1 2026. quantpillar.com
2. Octus. “Private-Credit Exposure to Veterinary Rollups Shows Growing Dispersion …” January 16, 2026. octus.com
3. Capstone Partners. “Pet Sector M&A Update.” April 10, 2026. capstonepartners.com
4. Provident Healthcare Partners. “Q2 2024 Veterinary Services Update.” 2024. providenthp.com
5. VetIntegrations. “Roll Call: North America’s Biggest Veterinary Consolidators and Groups.” December 8, 2022. vetintegrations.com
6. R.L. Hulett. “Pet M&A Update, Q4 2025.” Published February 2026. rlhulett.com

Veterinary practice operations and site-level evidence

7. American Veterinary Medical Association. “Benchmarking Data Plus Elevating Efficiency Equals Practice Productivity.” October 15, 2025. avma.org
8. American Veterinary Medical Association. “Increasing Practice Profitability Requires Benchmarking, Defining Core Values.” November 18, 2024; updated May 29, 2025. avma.org
9. iVET360. “2026 Veterinary Industry Benchmark Report.” April 9, 2026. ivet360.com
10. Today’s Veterinary Business. “Should You Buy a No-Lo Practice?” December 1, 2019. todaysveterinarybusiness.com